Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.
Xylinas E, Kluth LA, Rieken M, Lee RK, Elghouayel M, Ficarra V, Margulis V, Lotan Y, Rouprêt M, Martinez-Salamanca JI, Matsumoto K, Seitz C, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF; UTUC Collaboration. Xylinas E, et al. Among authors: zerbib m. BJU Int. 2014 Jul;114(1):56-61. doi: 10.1111/bju.12400. BJU Int. 2014. PMID: 24053463
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF; Upper Tract Urothelial Carcinoma Collaboration. Xylinas E, et al. Among authors: zerbib m. Eur Urol. 2014 Jan;65(1):210-7. doi: 10.1016/j.eururo.2012.04.052. Epub 2012 May 4. Eur Urol. 2014. PMID: 22579047
Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.
Xylinas E, Colin P, Audenet F, Phe V, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Polguer T, Ruffion A, Valeri A, Rozet F, Long JA, Zerbib M, Rouprêt M. Xylinas E, et al. Among authors: zerbib m. World J Urol. 2013 Feb;31(1):61-8. doi: 10.1007/s00345-012-0957-3. Epub 2012 Sep 30. World J Urol. 2013. PMID: 23053211
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
Xylinas E, Rink M, Margulis V, Faison T, Comploj E, Novara G, Raman JD, Lotan Y, Guillonneau B, Weizer A, Pycha A, Scherr DS, Seitz C, Sun M, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Gönen M, Shariat SF; UTUC Collaboration. Xylinas E, et al. Among authors: zerbib m. J Urol. 2013 Feb;189(2):468-73. doi: 10.1016/j.juro.2012.09.036. Epub 2012 Dec 14. J Urol. 2013. PMID: 23253960
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E, Novara G, Raman JD, Lotan Y, Weizer A, Roupret M, Pycha A, Scherr DS, Seitz C, Ficarra V, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Shariat SF; UTUC Collaboration. Xylinas E, et al. Among authors: zerbib m. BJU Int. 2013 Aug;112(4):453-61. doi: 10.1111/j.1464-410X.2012.11649.x. Epub 2013 Mar 6. BJU Int. 2013. PMID: 23464979 Free article.
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF. Xylinas E, et al. Among authors: zerbib m. Eur J Cancer. 2013 May;49(8):1889-97. doi: 10.1016/j.ejca.2013.02.001. Epub 2013 Mar 4. Eur J Cancer. 2013. PMID: 23466126
Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Hurel S, Rouprêt M, Ouzzane A, Rozet F, Xylinas E, Zerbib M, Berod AA, Ruffion A, Adam E, Cussenot O, Houlgatte A, Phé V, Nouhaud FX, Bensadoun H, Delage F, Guillotreau J, Guy L, Karsenty G, De La Taille A, Colin P; French Collaborative National Database on UTUC. Hurel S, et al. Among authors: zerbib m. BJU Int. 2013 Jun;111(8):1199-207. doi: 10.1111/bju.12116. Epub 2013 Apr 12. BJU Int. 2013. PMID: 23650914
Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours.
Hollande C, Colin P, de La Motte Rouge T, Audenet F, Yates DR, Phé V, Ouzzane A, Droupy S, Ruffion A, de La Taille A, Guy L, Cussenot O, Rozet F, Xylinas E, Zerbib M, Spano JP, Khayat D, Bitker MO, Rouprêt M; French Collaborative National Working-Group on UTUC. Hollande C, et al. Among authors: zerbib m. BJU Int. 2014 Apr;113(4):574-80. doi: 10.1111/bju.12308. Epub 2013 Aug 13. BJU Int. 2014. PMID: 23937547
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Rouprêt M, Aziz A, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Walton T, Karakiewicz PI, Montorsi F, Zerbib M, Scherr DS, Shariat SF; UTUC Collaboration. Xylinas E, et al. Among authors: zerbib m. Eur Urol. 2014 Mar;65(3):650-8. doi: 10.1016/j.eururo.2013.09.003. Epub 2013 Sep 19. Eur Urol. 2014. PMID: 24070577
408 results